The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms
Explore this paper's citation graph
Summary
The result is an enhanced, contemporary, evidence-based classification of myeloid and histiocytic/dendritic neoplasms, rooted in molecular biology and an organizational structure that permits future scalability as new discoveries continue to inexorably inform future editions.
- Type
- review
- Published
- 2022-06-22
- Cited by
- 3,644
- References
- 124
- Access
- Open access
- OpenAlex
- https://openalex.org/W4283271244
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:249893859
Keywords
Histiocyte, Myeloid, Disease, Hematologic Neoplasms, Medicine
References
- Clinical, immunophenotypic, and molecular characteristics of well-differentiated systemic mastocytosis.
- ALK-positive histiocytosis: an expanded clinicopathologic spectrum and frequent presence of KIF5B-ALK fusion
- CEBPA methylation and mutation in myelodysplastic syndrome
- Peripheral blood cells from children with RASopathies show enhanced spontaneous colonies growth in vitro and hyperactive RAS signaling
- Pure erythroid leukemia: a reassessment of the entity using the 2008 World Health Organization classification
- Clonally related Histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of 7 cases
- Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes.
- Prognostic significance of pronormoblasts in erythrocyte predominant myelodysplastic patients
- Safety and efficacy of imatinib in CML over a period of 10 years: data from the randomized CML-study IV
- Characteristic repartition of monocyte subsets as a diagnostic signature of chronic myelomonocytic leukemia.
- Follicular lymphoma transformation into histiocytic sarcoma: indications for a common neoplastic progenitor
- A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin
- Diagnosis of Myelodysplastic Syndrome Among a Cohort of 119 Patients With Fanconi Anemia
- Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
- Overexpression of wild-type or mutants forms of CEBPA alter normal human hematopoiesis
- Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone.
- Flow cytometry thresholds of myeloperoxidase detection to discriminate between acute lymphoblastic or myeloblastic leukaemia
- ALK+ histiocytosis: a novel type of systemic histiocytic proliferative disorder of early infancy.
- CSF3R T618I is a highly prevalent and specific mutation in chronic neutrophilic leukemia
- Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
Cited by
- Managing the unmanageable: evidence-driven approaches to real-world patient prototypes of TP53-mutant myelodysplastic neoplasms and acute myeloid leukemia
- Molecular Genetics of Thrombotic Myeloproliferative Neoplasms: Implications in Precision Oncology
- Myeloproliferative neoplasms
- À propos des auteurs
- Clinical Significance of Clonal Hematopoiesis of Indeterminate Potential in Hematology and Cardiovascular Disease
- Systemic Mastocytosis and Other Entities Involving Mast Cells: A Practical Review and Update
- When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms
- Inflammasomes—New Contributors to Blood Diseases
- Aktueller diagnostischer Standard und Risikostratifizierung der AML
- Molecular Pathways in Clonal Hematopoiesis: From the Acquisition of Somatic Mutations to Transformation into Hematologic Neoplasm
- SLIT2 promoter hypermethylation-mediated SLIT2-IT1/miR-218 repression drives leukemogenesis and predicts adverse prognosis in myelodysplastic neoplasm
- Contemporary and future strategies in polycythemia vera.
- Clonal hematopoiesis of indeterminate potential: clinical relevance of an incidental finding in liquid profiling
- Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management
- CHIPing away the progression potential of CHIP: A new reality in the making.
- Clinical Outcomes of Adults with Systemic Mastocytosis: A 15-Year Multidisciplinary Experience
- Challenges of diagnosing and managing pre-fibrotic myelofibrosis: A case-based and practical approach.
- Neurological Involvement in Pediatric Patients with Acute Leukemia: A Retrospective Cohort
- Current status and future perspectives in targeted therapy of NPM1-mutated AML
- 2021 WHO Classification of Lung Cancer: A Globally Applicable and Molecular Biomarker-Relevant Classification.
Related papers
- Histiocytic syndromes and a review of medical literatures
- Two types of histiocytic syndromes in one infant.
- [Histiocytic proliferative diseases].
- Cerebrospinal fluid cytology in histiocytic proliferative disorders.
- Analysis of Monocyte and Histiocytic Cell Populations in Bone Marrow of Patients with Confirmed and Suspected Cases of Reactive Histocytosis
- Histiocytic medullary reticulosis.
- [WHO Classification of Tumors of Hematopoietic and Lymphoid Tissues, 2022 (5th edition): Myeloid and Histiocytic Tumors].